China expects H7N9 vaccine in 7 months

China officially began a H7N9 research project this week and expects to have a vaccine ready in 7 months. Meanwhile, there is some confusion as to how China and Taiwan will collaborate. The Taiwanese president called for cooperation, while his health minister said the island will go it alone. Article | More | More

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.